Patent 11109883 was granted and assigned to Bridgepoint Medical, Inc. on September, 2021 by the United States Patent and Trademark Office.
Devices and methods for exploiting intramural (e.g., subintimal) space of a vascular wall to facilitate the treatment of vascular disease, particularly total occlusions. For example, the devices and methods disclosed herein may be used to visually define the vessel wall boundary, protect the vessel wall boundary from perforation, bypass an occlusion, and/or remove an occlusion.